BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 27145271)

  • 1. EphB6 overexpression and Apc mutation together promote colorectal cancer.
    Xu D; Yuan L; Liu X; Li M; Zhang F; Gu XY; Zhang D; Yang Y; Cui B; Tong J; Zhou J; Yu Z
    Oncotarget; 2016 May; 7(21):31111-21. PubMed ID: 27145271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determining the effects of Ephrin Type B Receptor 6 and Type A Receptor 3 on facilitating colorectal epithelial cell malignant transformation.
    Wang J; Zhang Y; Ma J; Yang C; Wang M; Lv J; Wang Y; Miao D; Wang Y; Li M; Chai C; Jiang S; Tong J; Li M; Yu Z
    Neoplasma; 2021 Sep; 68(5):955-964. PubMed ID: 34196214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of EphB6 protein expression in human colorectal cancer correlates with poor prognosis.
    Peng L; Tu P; Wang X; Shi S; Zhou X; Wang J
    J Mol Histol; 2014 Oct; 45(5):555-63. PubMed ID: 24912672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of the EPH receptor B6 contributes to colorectal cancer metastasis.
    Mateo-Lozano S; Bazzocco S; Rodrigues P; Mazzolini R; Andretta E; Dopeso H; Fernández Y; Del Llano E; Bilic J; Suárez-López L; Macaya I; Cartón-García F; Nieto R; Jimenez-Flores LM; de Marcondes PG; Nuñez Y; Afonso E; Cacci K; Hernández-Losa J; Landolfi S; Abasolo I; Ramón Y Cajal S; Mariadason JM; Schwartz S; Matsui T; Arango D
    Sci Rep; 2017 Mar; 7():43702. PubMed ID: 28262839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gasdermin C Is Upregulated by Inactivation of Transforming Growth Factor β Receptor Type II in the Presence of Mutated Apc, Promoting Colorectal Cancer Proliferation.
    Miguchi M; Hinoi T; Shimomura M; Adachi T; Saito Y; Niitsu H; Kochi M; Sada H; Sotomaru Y; Ikenoue T; Shigeyasu K; Tanakaya K; Kitadai Y; Sentani K; Oue N; Yasui W; Ohdan H
    PLoS One; 2016; 11(11):e0166422. PubMed ID: 27835699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.
    Moon BS; Jeong WJ; Park J; Kim TI; Min do S; Choi KY
    J Natl Cancer Inst; 2014 Feb; 106(2):djt373. PubMed ID: 24491301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EphA3 promotes malignant transformation of colorectal epithelial cells by upregulating oncogenic pathways.
    Li M; Yang C; Liu X; Yuan L; Zhang F; Wang M; Miao D; Gu X; Jiang S; Cui B; Tong J; Yu Z
    Cancer Lett; 2016 Dec; 383(2):195-203. PubMed ID: 27721017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of liver-intestine cadherin (Cadherin 17) expression, ERK phosphorylation and WNT signaling in EPHB6 receptor-expressing MDA-MB-231 cells.
    Bhushan L; Tavitian N; Dey D; Tumur Z; Parsa C; Kandpal RP
    Cancer Genomics Proteomics; 2014; 11(5):239-49. PubMed ID: 25331796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EphB receptor activity suppresses colorectal cancer progression.
    Batlle E; Bacani J; Begthel H; Jonkheer S; Gregorieff A; van de Born M; Malats N; Sancho E; Boon E; Pawson T; Gallinger S; Pals S; Clevers H
    Nature; 2005 Jun; 435(7045):1126-30. PubMed ID: 15973414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA CASC11 interacts with hnRNP-K and activates the WNT/β-catenin pathway to promote growth and metastasis in colorectal cancer.
    Zhang Z; Zhou C; Chang Y; Zhang Z; Hu Y; Zhang F; Lu Y; Zheng L; Zhang W; Li X; Li X
    Cancer Lett; 2016 Jun; 376(1):62-73. PubMed ID: 27012187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of MYC-regulated long noncoding RNAs in cell cycle regulation and tumorigenesis.
    Kim T; Jeon YJ; Cui R; Lee JH; Peng Y; Kim SH; Tili E; Alder H; Croce CM
    J Natl Cancer Inst; 2015 Apr; 107(4):. PubMed ID: 25663692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine kinase-deficient EphB6 receptor-dependent alterations in proteomic profiles of invasive breast carcinoma cells as determined by difference gel electrophoresis.
    Kandpal RP
    Cancer Genomics Proteomics; 2010; 7(5):253-60. PubMed ID: 20952760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression profile reveals deregulation of pregnancy specific beta1 glycoprotein 9 early during colorectal carcinogenesis.
    Salahshor S; Goncalves J; Chetty R; Gallinger S; Woodgett JR
    BMC Cancer; 2005 Jun; 5():66. PubMed ID: 15982419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The EPHB6 receptor tyrosine kinase is a metastasis suppressor that is frequently silenced by promoter DNA hypermethylation in non-small cell lung cancer.
    Yu J; Bulk E; Ji P; Hascher A; Tang M; Metzger R; Marra A; Serve H; Berdel WE; Wiewroth R; Koschmieder S; Müller-Tidow C
    Clin Cancer Res; 2010 Apr; 16(8):2275-83. PubMed ID: 20371680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced EphB6 protein in gastric carcinoma and associated lymph nodes suggests EphB6 as a gastric tumor and metastasis inhibitor.
    Liu J; Xu B; Xu G; Zhang X; Yang X; Wang J
    Cancer Biomark; 2017 Jul; 19(3):241-248. PubMed ID: 28453458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
    Toosi BM; El Zawily A; Truitt L; Shannon M; Allonby O; Babu M; DeCoteau J; Mousseau D; Ali M; Freywald T; Gall A; Vizeacoumar FS; Kirzinger MW; Geyer CR; Anderson DH; Kim T; Welm AL; Siegel P; Vizeacoumar FJ; Kusalik A; Freywald A
    Oncogene; 2018 Jul; 37(30):4073-4093. PubMed ID: 29700392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pleiotropic Effects of PPARD Accelerate Colorectal Tumorigenesis, Progression, and Invasion.
    Liu Y; Deguchi Y; Tian R; Wei D; Wu L; Chen W; Xu W; Xu M; Liu F; Gao S; Jaoude JC; Chrieki SP; Moussalli MJ; Gagea M; Morris J; Broaddus RR; Zuo X; Shureiqi I
    Cancer Res; 2019 Mar; 79(5):954-969. PubMed ID: 30679176
    [No Abstract]   [Full Text] [Related]  

  • 20. Signal transduction cross-talk during colorectal tumorigenesis.
    Liu X; Lazenby AJ; Siegal GP
    Adv Anat Pathol; 2006 Sep; 13(5):270-4. PubMed ID: 16998321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.